INDIANAPOLIS, March 5, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting Nectin-4, KRAS G12D, and BRM (SMARCA2) will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 5-10 in San Diego. The presentations will include new preclinical data for a… Continue reading Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Category: Newswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Archer-Daniels-Midland Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – ADM
NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Archer-Daniels-Midland Company (NYSE: ADM) between April 30, 2020 and January 22, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2024 lead plaintiff deadline. SO WHAT: If you purchased Archer-Daniels-Midland securities… Continue reading ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Archer-Daniels-Midland Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – ADM
Nuvei Announces Fourth Quarter and Fiscal 2023 Results
Nuvei reports in U.S. dollars and in accordance with International Financial Reporting Standards (“IFRS”) MONTREAL, March 5, 2024 /PRNewswire/ — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, today reported its financial results for the three months and year ended December 31, 2023. The Company’s results are also included… Continue reading Nuvei Announces Fourth Quarter and Fiscal 2023 Results
BCN Strengthens Commitment to Service Delivery with Appointment of Tom Boggs as Vice President
MORRISTOWN, N.J., March 5, 2024 /PRNewswire/ — BCN, a U.S.-based communications technology solution provider focused on multi-location businesses announces the appointment of Tom Boggs as Vice President of Service Delivery, effective March 1st. Continue Reading BCN 30th Anniversary Logo Julian Jacquez, BCN President & COO Tom Boggs, BCN VP Service Delivery Tom Boggs joins BCN… Continue reading BCN Strengthens Commitment to Service Delivery with Appointment of Tom Boggs as Vice President
Commerce Department Announces Affirmative Preliminary Subsidy Determinations on Imports of Aluminum Extrusions from China, Indonesia, Mexico, and Turkey, Wiley Rein LLP Reports
WASHINGTON, March 5, 2024 /PRNewswire/ — Today, the U.S. Department of Commerce announced its preliminary finding that the governments of China, Indonesia, Mexico, and Turkey unfairly subsidize their aluminum extrusion industries. Commerce calculated affirmative preliminary countervailing duties from each country in the following ranges: imports from China at rates of 15.41% to 169.66%, imports from… Continue reading Commerce Department Announces Affirmative Preliminary Subsidy Determinations on Imports of Aluminum Extrusions from China, Indonesia, Mexico, and Turkey, Wiley Rein LLP Reports
FIRST BANK AWARDED GREENWICH EXCELLENCE AWARDS IN SMALL BUSINESS BANKING
SOUTHERN PINES, N.C., March 5, 2024 /PRNewswire/ — First Bank has been recognized by Coalition Greenwich in multiple Small Business Banking categories as an outstanding achiever after interviews with nearly 28,000 small business owners. First Bank earned the following 2023 Greenwich Excellence Awards: U.S. Small Business Banking: National Winner Overall Satisfaction U.S. Small Business Banking:… Continue reading FIRST BANK AWARDED GREENWICH EXCELLENCE AWARDS IN SMALL BUSINESS BANKING
Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024
CAMBRIDGE, Mass., March 5, 2024 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced upcoming preclinical data poster presentations further characterizing the preclinical profiles of its novel HER2-selective inhibitor, NVL-330, and novel ROS1-selective inhibitor, zidesamtinib (NVL-520), at the American Association… Continue reading Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024
Europa Wire: Škoda Auto Unveils Cutting-Edge Laurin & Klement Kampus: A Hub of Innovation and Sustainability001012
Škoda Auto Unveils Cutting-Edge Laurin & Klement Kampus: A Hub of Innovation and Sustainability (IN BRIEF) Škoda Auto celebrates the completion of its new headquarters, the Laurin & Klement Kampus (LKK), in Mladá Boleslav, boasting state-of-the-art facilities designed to accommodate up to 2,000 employees. The interconnected complex, built within two years, aims to foster collaboration… Continue reading Europa Wire: Škoda Auto Unveils Cutting-Edge Laurin & Klement Kampus: A Hub of Innovation and Sustainability001012
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Palo Alto Networks, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PANW
NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Palo Alto Networks, Inc. (NASDAQ: PANW) between August 18, 2023 and February 20, 2024, both dates inclusive (the “Class Period”), of the important April 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased… Continue reading ROSEN, NATIONAL TRIAL COUNSEL, Encourages Palo Alto Networks, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PANW
BNTX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and October 13, 2023, both dates inclusive (the “Class Period”), of the important March 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased BioNTech securities during… Continue reading BNTX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX